Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...
This is a breaking news story. Details will be added soon. Please refresh the page for latest version.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback